27 October 2017 - Deborah Wilkes
Archived
GlaxoSmithKline has commented on Pfizer's recent announcement that it is considering a range of strategic alternatives, including divestment, for its global Consumer Healthcare business.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.